WPI Related Corporate News
-
Shire plc (SHPG) Settles INTUNIV Litigation with Actavis (ACT), Watson (WPI)
-
Pfizer (PFE) Ticks Higher on Extension of Celebrex Exclusivity; Unleases Lawsuits (TEVA) (MYL)
-
Watson Pharma (WPI) Acquires Uteron Pharma SA in $305M Deal
-
Watson Pharma (WPI) to Reorganize Corona, CA, Facility; Sees Charges
-
Watson Pharma (WPI) Unit Receives Approval for Generic Lysteda ANDA
-
Watson Pharma (WPI) Affirms Challenge of Velcade
-
Depomed (DEPO) Withdraws Two Suits Against Gralise ANDA Filers
-
Transcept (TSPT) Dismisses Action Against Watcon (WPI) Over Generic Intermezzo ANDA
-
Watson Pharma (WPI) Unit Receives FDA Approval for Generic Revatio ANDA (PFE)
-
Mylan (MYL) Files Expedited Motion Related to Watson's (WPI) Pioglitazone ANDA
-
Watson (WPI) Sell Minority Stake in Moksha8 for $47M; Expands Relationship
-
Watson Pharma (WPI) Receives FTC Nod for Actavis Acquisition
-
Watson (WPI) Gets FDA Approval for Generic Sanctura XR (AGN)
-
Watson (WPI) Receives FDA Approval for Generic Avapro (SNY)
-
Watson Pharma (WPI) Receives EC Approval to Acquire Actavis Group
-
Watson (WPI) Issues Voluntary Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets
-
Transcept (TSPT) Files Action Against Watson (WPI), Actavis Over '628 Patent
-
Watson Pharma (WPI) Sues FDA Over Actos Shared Exclusivity Entitlement
-
Watson Pharma (WPI) Receives FDA Approval for Generic Pulmicort RESPULES (AZN)
-
Watson Pharma (WPI) Confirms Patent Challenge for Xopenox HFA
-
Watson Pharma (WPI) Confirms Patent Challenge on Epiduo Gel
-
Watson Pharma (WPI) Receives FDA Approval for ANDA for Next Choice ONE DOSE
-
Watson (WPI) Gets Second Request from FTC on Actavis Group Acquisition
-
Watson (WPI) Unit Gets FDA Approval for Generic ARTHROTEC ANDA
-
Watson Pharma (WPI) Confirms Patent Challenge of Pristiq
-
Watson Pharma (WPI) Affirms Delaware Court of Appeals Ruling that Sanctura XR Patents are Invalid
-
Endo (ENDP), Watson Pharma (WPI) Settle LIDODERM Litigation
-
Watson Pharma (WPI) Confirms Patent Challenge on Testim from Auxilium
-
Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
-
Watson Pharma (WPI) Forms Global Integration Manangement Office to Support Actavis Purchase
-
Watson Pharma (WPI) Reports Changes to Executive Team Following Actavis Acquisition
-
Watson (API) Affirms Submission of NDA to FDA for Generic Glumetza (DEPO)
-
Valeant (VRX), DepoMed (DEPO) Sue Watson (WPI) Over Generic Glumetza
-
Auxilium (AUXL) Says Watson (WPI) Files ANDA with Paragraph IV for Testosterone Gel
-
Watson (WPI) Gets FDA Approval for Generic VANCOCIN Tabs (VPHM)
-
Watson (WPI) Affirms Patent Claims on Sanctura XR Were Ruled Invalid
-
Watson Pharma (WPI) Confirms Patent Challenges on LUMIGAN, LATISSE
-
Watson Pharma (WPI) Unit Gets FDA Approval for Generic BONIVA ANDA
-
Watson Pharma (WPI) Files ANDA with FDA for Generic NIASPAN
-
Watson (WPI) Affirms Filing of ANDA for Generic BYSTOLIC by Subsidiary
-
Watson Pharma (WPI) Initiates Esmva Phase 3 in Women w/ Uterine Fibroids
-
Watson (WPI) Launches Generic Version of Abbott's PROMETRIUM
-
Columbia Labs (CBRX) Cuts 42% of Workforce, Will Explore Strategic Options
-
Watson (WPI), Columbia Labs (CBRX) Get CRL from FDA for Progesterone Gel
-
Columbia Labs (CBRX) Transfers Progesterone 8% NDA to Watson (WPI)
-
Watson (WPI) reaches settlement with Janssen Pharma related to ORTHO TRI-CYCLEN(R) LO
-
Watson Pharma (WPI) Says Generic Lidoderm ANDA 'On Track'; Will Not Comment Further
-
Watson Pharma (WPI) to Establish New Global R&D Tech Center in New Jersey
-
Watson Pharma (WPI) to Invest $4.5M in Global R&D Tech Center
-
Lannett (LCI) Gets FDA Approval for Generic Microzide Caps (WPI)
Back to WPI Stock Lookup
